

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine metabolic process (GO:0006558) | 5.04467699 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.04467699 |
| 3 | sulfur amino acid catabolic process (GO:0000098) | 5.03668954 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.03017686 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.03017686 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.99884080 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.47627497 |
| 8 | homocysteine metabolic process (GO:0050667) | 4.34329695 |
| 9 | bile acid and bile salt transport (GO:0015721) | 4.28166034 |
| 10 | regulation of triglyceride catabolic process (GO:0010896) | 4.24375105 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 4.21147586 |
| 12 | urea metabolic process (GO:0019627) | 4.20820521 |
| 13 | urea cycle (GO:0000050) | 4.20820521 |
| 14 | cysteine metabolic process (GO:0006534) | 4.18655908 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.16580183 |
| 16 | intestinal cholesterol absorption (GO:0030299) | 4.14715605 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 4.14399296 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 4.13701988 |
| 19 | protein carboxylation (GO:0018214) | 4.09509800 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.09509800 |
| 21 | tryptophan catabolic process (GO:0006569) | 4.06264902 |
| 22 | indole-containing compound catabolic process (GO:0042436) | 4.06264902 |
| 23 | indolalkylamine catabolic process (GO:0046218) | 4.06264902 |
| 24 | phospholipid efflux (GO:0033700) | 4.05178283 |
| 25 | regulation of cholesterol homeostasis (GO:2000188) | 4.03805679 |
| 26 | bile acid biosynthetic process (GO:0006699) | 3.85339109 |
| 27 | regulation of fibrinolysis (GO:0051917) | 3.84865367 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 3.83767579 |
| 29 | negative regulation of sterol transport (GO:0032372) | 3.83673554 |
| 30 | negative regulation of cholesterol transport (GO:0032375) | 3.83673554 |
| 31 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.82318410 |
| 32 | desmosome organization (GO:0002934) | 3.81335313 |
| 33 | tryptophan metabolic process (GO:0006568) | 3.78818888 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.78528465 |
| 35 | regulation of cholesterol esterification (GO:0010872) | 3.76090737 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 3.75714878 |
| 37 | triglyceride homeostasis (GO:0070328) | 3.71738813 |
| 38 | acylglycerol homeostasis (GO:0055090) | 3.71738813 |
| 39 | regulation of protein activation cascade (GO:2000257) | 3.71667982 |
| 40 | complement activation, alternative pathway (GO:0006957) | 3.71395445 |
| 41 | intestinal absorption (GO:0050892) | 3.68278653 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.67403577 |
| 43 | reverse cholesterol transport (GO:0043691) | 3.67098723 |
| 44 | bile acid metabolic process (GO:0008206) | 3.66464994 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 3.65138988 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 3.65138988 |
| 47 | macromolecular complex remodeling (GO:0034367) | 3.65138988 |
| 48 | plasma lipoprotein particle clearance (GO:0034381) | 3.62762371 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 3.62473501 |
| 50 | lysine metabolic process (GO:0006553) | 3.60631267 |
| 51 | lysine catabolic process (GO:0006554) | 3.60631267 |
| 52 | regulation of complement activation (GO:0030449) | 3.53480022 |
| 53 | drug catabolic process (GO:0042737) | 3.50636835 |
| 54 | cellular glucuronidation (GO:0052695) | 3.47504500 |
| 55 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.43211842 |
| 56 | flavonoid metabolic process (GO:0009812) | 3.42924730 |
| 57 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.40470515 |
| 58 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.40470515 |
| 59 | hemidesmosome assembly (GO:0031581) | 3.39935478 |
| 60 | fibrinolysis (GO:0042730) | 3.39569869 |
| 61 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.38795003 |
| 62 | serine family amino acid catabolic process (GO:0009071) | 3.38505683 |
| 63 | endothelial cell chemotaxis (GO:0035767) | 3.34474037 |
| 64 | regulation of bile acid biosynthetic process (GO:0070857) | 3.34199879 |
| 65 | ketone body metabolic process (GO:1902224) | 3.32178736 |
| 66 | positive regulation of lipid catabolic process (GO:0050996) | 3.31626092 |
| 67 | aromatic amino acid family metabolic process (GO:0009072) | 3.30289027 |
| 68 | epoxygenase P450 pathway (GO:0019373) | 3.30244996 |
| 69 | lipoprotein metabolic process (GO:0042157) | 3.30072089 |
| 70 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.28727531 |
| 71 | Golgi transport vesicle coating (GO:0048200) | 3.26640425 |
| 72 | COPI coating of Golgi vesicle (GO:0048205) | 3.26640425 |
| 73 | cholesterol homeostasis (GO:0042632) | 3.26474476 |
| 74 | cellular modified amino acid catabolic process (GO:0042219) | 3.25245165 |
| 75 | basement membrane organization (GO:0071711) | 3.23961162 |
| 76 | sterol homeostasis (GO:0055092) | 3.22956358 |
| 77 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.18398306 |
| 78 | ethanol oxidation (GO:0006069) | 3.17663786 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 3.16492371 |
| 80 | cholesterol efflux (GO:0033344) | 3.15086159 |
| 81 | fatty acid oxidation (GO:0019395) | 3.14941240 |
| 82 | negative regulation of fatty acid transport (GO:2000192) | 3.13361477 |
| 83 | fatty acid beta-oxidation (GO:0006635) | 3.13242380 |
| 84 | alpha-amino acid catabolic process (GO:1901606) | 3.13173226 |
| 85 | tyrosine metabolic process (GO:0006570) | 3.11428948 |
| 86 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.10316735 |
| 87 | low-density lipoprotein particle clearance (GO:0034383) | 3.09195588 |
| 88 | ethanol metabolic process (GO:0006067) | 3.08564828 |
| 89 | glucuronate metabolic process (GO:0019585) | 3.07391224 |
| 90 | uronic acid metabolic process (GO:0006063) | 3.07391224 |
| 91 | lipid oxidation (GO:0034440) | 3.07389380 |
| 92 | valine metabolic process (GO:0006573) | 3.07327607 |
| 93 | negative regulation of lipase activity (GO:0060192) | 3.06727436 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 3.05984034 |
| 95 | positive regulation of fatty acid oxidation (GO:0046321) | 3.02906543 |
| 96 | protein retention in ER lumen (GO:0006621) | 3.02151976 |
| 97 | protein-lipid complex assembly (GO:0065005) | 3.01811428 |
| 98 | primary alcohol catabolic process (GO:0034310) | 3.00193279 |
| 99 | adhesion of symbiont to host (GO:0044406) | 2.99697044 |
| 100 | phospholipid homeostasis (GO:0055091) | 2.98461173 |
| 101 | benzene-containing compound metabolic process (GO:0042537) | 2.97110066 |
| 102 | carnitine metabolic process (GO:0009437) | 2.96428684 |
| 103 | drug metabolic process (GO:0017144) | 2.95638408 |
| 104 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.93432050 |
| 105 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.93240376 |
| 106 | regulation of cholesterol metabolic process (GO:0090181) | 2.92764895 |
| 107 | regulation of plasminogen activation (GO:0010755) | 2.92713621 |
| 108 | NADH metabolic process (GO:0006734) | 2.92181102 |
| 109 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.92026986 |
| 110 | omega-hydroxylase P450 pathway (GO:0097267) | 2.91887667 |
| 111 | fatty acid catabolic process (GO:0009062) | 2.91194921 |
| 112 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.89499045 |
| 113 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.89281643 |
| 114 | GDP-mannose metabolic process (GO:0019673) | 2.88869104 |
| 115 | drug transmembrane transport (GO:0006855) | 2.88410546 |
| 116 | adhesion of symbiont to host cell (GO:0044650) | 2.84362108 |
| 117 | virion attachment to host cell (GO:0019062) | 2.84362108 |
| 118 | negative regulation of cell size (GO:0045792) | 2.83007143 |
| 119 | epithelial cell-cell adhesion (GO:0090136) | 2.80493702 |
| 120 | semaphorin-plexin signaling pathway (GO:0071526) | 2.80363485 |
| 121 | proline biosynthetic process (GO:0006561) | 2.76650306 |
| 122 | glutathione biosynthetic process (GO:0006750) | 2.76320394 |
| 123 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.75783752 |
| 124 | proline metabolic process (GO:0006560) | 2.71975946 |
| 125 | exogenous drug catabolic process (GO:0042738) | 2.71136352 |
| 126 | barbed-end actin filament capping (GO:0051016) | 2.68189991 |
| 127 | type B pancreatic cell proliferation (GO:0044342) | 2.65841460 |
| 128 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.62617809 |
| 129 | multicellular organismal water homeostasis (GO:0050891) | 2.60653890 |
| 130 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.58724508 |
| 131 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.55821112 |
| 132 | cell-cell junction maintenance (GO:0045217) | 2.52728102 |
| 133 | 4-hydroxyproline metabolic process (GO:0019471) | 2.51541260 |
| 134 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.48692507 |
| 135 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.47879752 |
| 136 | UV protection (GO:0009650) | 2.46487932 |
| 137 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.45247334 |
| 138 | amyloid precursor protein catabolic process (GO:0042987) | 2.45143213 |
| 139 | mannose metabolic process (GO:0006013) | 2.42757307 |
| 140 | skin morphogenesis (GO:0043589) | 2.42587085 |
| 141 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.42372539 |
| 142 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.42139279 |
| 143 | negative regulation of lipid transport (GO:0032369) | 2.39952884 |
| 144 | regulation of water loss via skin (GO:0033561) | 2.39305322 |
| 145 | cell-substrate junction assembly (GO:0007044) | 2.38708607 |
| 146 | regulation of apoptotic cell clearance (GO:2000425) | 2.37298557 |
| 147 | macroautophagy (GO:0016236) | 2.37223911 |
| 148 | biotin metabolic process (GO:0006768) | 2.36918969 |
| 149 | regulation of extracellular matrix disassembly (GO:0010715) | 2.33803486 |
| 150 | protein heterotrimerization (GO:0070208) | 2.33185161 |
| 151 | negative regulation of hemostasis (GO:1900047) | 2.31380881 |
| 152 | negative regulation of blood coagulation (GO:0030195) | 2.31380881 |
| 153 | opsonization (GO:0008228) | 2.30784109 |
| 154 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.30322275 |
| 155 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.29424142 |
| 156 | cell volume homeostasis (GO:0006884) | 2.27262123 |
| 157 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.26714268 |
| 158 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.24265139 |
| 159 | cell-substrate adherens junction assembly (GO:0007045) | 2.23635662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.54225067 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.45942320 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.40358380 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.39519968 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.94842188 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.25710795 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.73946976 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.18955248 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.18161055 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.93749846 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.87866637 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.66417565 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.59466052 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.45363501 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.43708892 |
| 16 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.99942882 |
| 17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.99086095 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98027863 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.89616661 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.89291290 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.87275893 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.85284828 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.85028138 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83445765 |
| 25 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.77116868 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.73613208 |
| 27 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71566531 |
| 28 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.68958608 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.68081479 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.63708358 |
| 31 | * P68_20966046_ChIP-Seq_HELA_Human | 1.62902035 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62880322 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62437403 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61372080 |
| 35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.57183278 |
| 36 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.56700233 |
| 37 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.51497606 |
| 38 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.50611774 |
| 39 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50326683 |
| 40 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.47594181 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47309512 |
| 42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45331876 |
| 43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.44933721 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44622656 |
| 45 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.42221423 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.41706867 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40065751 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39936364 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37743481 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36775728 |
| 51 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.36116966 |
| 52 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.34990718 |
| 53 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33654873 |
| 54 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.31968946 |
| 55 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.29916500 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29209080 |
| 57 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.28050881 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25789963 |
| 59 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.24647467 |
| 60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22723244 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22328937 |
| 62 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.20951238 |
| 63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20542338 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19649986 |
| 65 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19368018 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19108549 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19071663 |
| 68 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17494505 |
| 69 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.17178264 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17137342 |
| 71 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15600911 |
| 72 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15600911 |
| 73 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14302684 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12740647 |
| 75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11828418 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11262955 |
| 77 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11204683 |
| 78 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11170915 |
| 79 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10326719 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09888201 |
| 81 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.09860258 |
| 82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09165975 |
| 83 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08890894 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08442805 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08428588 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07743027 |
| 87 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06279738 |
| 88 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05193578 |
| 89 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.04900157 |
| 90 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04406051 |
| 91 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02668427 |
| 92 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02640612 |
| 93 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99718133 |
| 94 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.99043164 |
| 95 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98493589 |
| 96 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.97539993 |
| 97 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96969327 |
| 98 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96303988 |
| 99 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.95619275 |
| 100 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.95451745 |
| 101 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94732106 |
| 102 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94563374 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94479172 |
| 104 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.94289776 |
| 105 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94286667 |
| 106 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93652096 |
| 107 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93068732 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92791182 |
| 109 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.91408300 |
| 110 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91120263 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90205743 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89422389 |
| 113 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89098374 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87051951 |
| 115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86719540 |
| 116 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.83205298 |
| 117 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83075106 |
| 118 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81806481 |
| 119 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81589623 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81589623 |
| 121 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81431294 |
| 122 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81414876 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80721894 |
| 124 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80721894 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80655243 |
| 126 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.78673915 |
| 127 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77826996 |
| 128 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.77807928 |
| 129 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77755672 |
| 130 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76853945 |
| 131 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76352019 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74732228 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74009503 |
| 134 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.72542569 |
| 135 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72320531 |
| 136 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72269550 |
| 137 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71642922 |
| 138 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71627956 |
| 139 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.70907204 |
| 140 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.70609627 |
| 141 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70460602 |
| 142 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70307940 |
| 143 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.67108156 |
| 144 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.66902630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.70500867 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.56939541 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.38812094 |
| 4 | MP0005365_abnormal_bile_salt | 4.14877463 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.94018646 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.39411293 |
| 7 | MP0005275_abnormal_skin_tensile | 3.13247598 |
| 8 | MP0003252_abnormal_bile_duct | 3.02033558 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.98525047 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.92483671 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.74635098 |
| 12 | MP0002796_impaired_skin_barrier | 2.68558880 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.63677438 |
| 14 | MP0009840_abnormal_foam_cell | 2.63116800 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.57739405 |
| 16 | MP0000751_myopathy | 2.44007858 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.39136584 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.28922922 |
| 19 | MP0004858_abnormal_nervous_system | 2.28484750 |
| 20 | MP0005083_abnormal_biliary_tract | 2.27191263 |
| 21 | MP0002060_abnormal_skin_morphology | 2.07854822 |
| 22 | MP0002254_reproductive_system_inflammat | 1.98763216 |
| 23 | MP0005332_abnormal_amino_acid | 1.90653469 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.81320547 |
| 25 | MP0005409_darkened_coat_color | 1.77916793 |
| 26 | MP0009384_cardiac_valve_regurgitation | 1.58656382 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.57937169 |
| 28 | MP0005501_abnormal_skin_physiology | 1.57913524 |
| 29 | MP0003195_calcinosis | 1.55728384 |
| 30 | MP0000609_abnormal_liver_physiology | 1.50809282 |
| 31 | MP0000579_abnormal_nail_morphology | 1.44994998 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.38929329 |
| 33 | MP0003453_abnormal_keratinocyte_physiol | 1.36752708 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.34980864 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.34714114 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.31966511 |
| 37 | MP0005330_cardiomyopathy | 1.30395636 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.23900471 |
| 39 | MP0005670_abnormal_white_adipose | 1.22697105 |
| 40 | MP0001216_abnormal_epidermal_layer | 1.21121462 |
| 41 | MP0003868_abnormal_feces_composition | 1.20849885 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.20105426 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.19687501 |
| 44 | MP0002249_abnormal_larynx_morphology | 1.18318876 |
| 45 | MP0003329_amyloid_beta_deposits | 1.16544080 |
| 46 | MP0000566_synostosis | 1.16197888 |
| 47 | MP0005023_abnormal_wound_healing | 1.15656259 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.15073585 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.14546625 |
| 50 | MP0002089_abnormal_postnatal_growth/wei | 1.12979731 |
| 51 | MP0005666_abnormal_adipose_tissue | 1.09674254 |
| 52 | MP0000467_abnormal_esophagus_morphology | 1.09223545 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.09161241 |
| 54 | MP0004272_abnormal_basement_membrane | 1.08892279 |
| 55 | MP0005451_abnormal_body_composition | 1.08763326 |
| 56 | MP0001243_abnormal_dermal_layer | 1.08256076 |
| 57 | MP0000767_abnormal_smooth_muscle | 1.07045014 |
| 58 | MP0005257_abnormal_intraocular_pressure | 1.06646530 |
| 59 | MP0010771_integument_phenotype | 1.01986569 |
| 60 | MP0009053_abnormal_anal_canal | 0.99354363 |
| 61 | MP0005503_abnormal_tendon_morphology | 0.98736466 |
| 62 | MP0003879_abnormal_hair_cell | 0.98217954 |
| 63 | MP0003941_abnormal_skin_development | 0.97777753 |
| 64 | MP0001958_emphysema | 0.97464435 |
| 65 | MP0005508_abnormal_skeleton_morphology | 0.95506328 |
| 66 | MP0002098_abnormal_vibrissa_morphology | 0.94659592 |
| 67 | MP0006138_congestive_heart_failure | 0.94159259 |
| 68 | MP0001756_abnormal_urination | 0.93594916 |
| 69 | MP0005595_abnormal_vascular_smooth | 0.92229296 |
| 70 | MP0003091_abnormal_cell_migration | 0.92167486 |
| 71 | MP0004947_skin_inflammation | 0.91303436 |
| 72 | MP0000678_abnormal_parathyroid_gland | 0.91296462 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 0.91282029 |
| 74 | MP0001881_abnormal_mammary_gland | 0.90525224 |
| 75 | MP0004130_abnormal_muscle_cell | 0.88937628 |
| 76 | MP0000377_abnormal_hair_follicle | 0.87963192 |
| 77 | MP0008260_abnormal_autophagy | 0.86780083 |
| 78 | MP0009278_abnormal_bone_marrow | 0.86771986 |
| 79 | MP0005165_increased_susceptibility_to | 0.86704260 |
| 80 | MP0010678_abnormal_skin_adnexa | 0.86415765 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85905404 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 0.84791706 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.84583742 |
| 84 | MP0010368_abnormal_lymphatic_system | 0.84372531 |
| 85 | MP0005375_adipose_tissue_phenotype | 0.83356633 |
| 86 | MP0004510_myositis | 0.83149750 |
| 87 | MP0000462_abnormal_digestive_system | 0.83115737 |
| 88 | MP0003075_altered_response_to | 0.82926462 |
| 89 | MP0000427_abnormal_hair_cycle | 0.82159914 |
| 90 | MP0000604_amyloidosis | 0.81683400 |
| 91 | MP0002108_abnormal_muscle_morphology | 0.80948745 |
| 92 | MP0002971_abnormal_brown_adipose | 0.80288494 |
| 93 | MP0006054_spinal_hemorrhage | 0.79907715 |
| 94 | MP0000750_abnormal_muscle_regeneration | 0.78898726 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.78718778 |
| 96 | MP0003186_abnormal_redox_activity | 0.77053787 |
| 97 | MP0000747_muscle_weakness | 0.76967609 |
| 98 | MP0000013_abnormal_adipose_tissue | 0.76755640 |
| 99 | MP0010030_abnormal_orbit_morphology | 0.76189752 |
| 100 | MP0000598_abnormal_liver_morphology | 0.75954885 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.75735472 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.75531969 |
| 103 | MP0000647_abnormal_sebaceous_gland | 0.75155858 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.74231590 |
| 105 | MP0009931_abnormal_skin_appearance | 0.73996139 |
| 106 | MP0003279_aneurysm | 0.71636942 |
| 107 | MP0001664_abnormal_digestion | 0.70168509 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.70092304 |
| 109 | MP0004087_abnormal_muscle_fiber | 0.69855649 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.69716946 |
| 111 | MP0000538_abnormal_urinary_bladder | 0.69004778 |
| 112 | MP0001764_abnormal_homeostasis | 0.68044489 |
| 113 | MP0000681_abnormal_thyroid_gland | 0.68013789 |
| 114 | MP0000762_abnormal_tongue_morphology | 0.67928016 |
| 115 | MP0002295_abnormal_pulmonary_circulatio | 0.66209829 |
| 116 | MP0004233_abnormal_muscle_weight | 0.66065417 |
| 117 | MP0001849_ear_inflammation | 0.65921313 |
| 118 | MP0000383_abnormal_hair_follicle | 0.65611029 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.63496701 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.62852331 |
| 121 | MP0005647_abnormal_sex_gland | 0.62247888 |
| 122 | MP0001191_abnormal_skin_condition | 0.61280934 |
| 123 | MP0002896_abnormal_bone_mineralization | 0.61128485 |
| 124 | MP0009379_abnormal_foot_pigmentation | 0.59738447 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.59333503 |
| 126 | MP0000537_abnormal_urethra_morphology | 0.59320309 |
| 127 | MP0005408_hypopigmentation | 0.58842088 |
| 128 | MP0005448_abnormal_energy_balance | 0.58369862 |
| 129 | MP0001542_abnormal_bone_strength | 0.57093191 |
| 130 | MP0005334_abnormal_fat_pad | 0.56958583 |
| 131 | MP0009764_decreased_sensitivity_to | 0.55702999 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.54909789 |
| 133 | MP0003724_increased_susceptibility_to | 0.53750467 |
| 134 | MP0001661_extended_life_span | 0.52991611 |
| 135 | MP0001765_abnormal_ion_homeostasis | 0.52802425 |
| 136 | MP0009115_abnormal_fat_cell | 0.52191612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 5.14132409 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.14041707 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.85893111 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.85243293 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.46559639 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.28409097 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 4.22538276 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 3.93158882 |
| 9 | Hypolipoproteinemia (HP:0010981) | 3.88998538 |
| 10 | Hypoalphalipoproteinemia (HP:0003233) | 3.88330783 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.76677913 |
| 12 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.57760652 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 3.51628826 |
| 14 | Vertebral compression fractures (HP:0002953) | 3.41586184 |
| 15 | Protrusio acetabuli (HP:0003179) | 3.39452261 |
| 16 | Malnutrition (HP:0004395) | 3.36180514 |
| 17 | Complement deficiency (HP:0004431) | 3.29206091 |
| 18 | Hyperammonemia (HP:0001987) | 3.27621203 |
| 19 | Fat malabsorption (HP:0002630) | 3.22876093 |
| 20 | Cervical subluxation (HP:0003308) | 3.22784864 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.22671383 |
| 22 | Premature rupture of membranes (HP:0001788) | 3.22624580 |
| 23 | Epidermoid cyst (HP:0200040) | 3.20771427 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.20703284 |
| 25 | Hyperglycinuria (HP:0003108) | 3.10858678 |
| 26 | Alopecia of scalp (HP:0002293) | 3.10044007 |
| 27 | Distal lower limb muscle weakness (HP:0009053) | 3.02767983 |
| 28 | Thin bony cortex (HP:0002753) | 3.02553784 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 2.97904602 |
| 30 | Ketosis (HP:0001946) | 2.94309103 |
| 31 | Ileus (HP:0002595) | 2.91025764 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.87046567 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 2.87046567 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 2.86229596 |
| 35 | Atrophic scars (HP:0001075) | 2.84653716 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.82054944 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.76968491 |
| 38 | Joint stiffness (HP:0001387) | 2.72458222 |
| 39 | Myocardial infarction (HP:0001658) | 2.70507769 |
| 40 | Abnormality of complement system (HP:0005339) | 2.69875588 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 2.66000338 |
| 42 | Increased connective tissue (HP:0009025) | 2.63413948 |
| 43 | Hyperglycinemia (HP:0002154) | 2.60796803 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.59489266 |
| 45 | Mucopolysacchariduria (HP:0008155) | 2.57874953 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.57874953 |
| 47 | Achilles tendon contracture (HP:0001771) | 2.57646366 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.57344017 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.57292370 |
| 50 | Peritonitis (HP:0002586) | 2.56157329 |
| 51 | Short nail (HP:0001799) | 2.54165138 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.52105068 |
| 53 | J-shaped sella turcica (HP:0002680) | 2.50671549 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50190384 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50190384 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50190384 |
| 57 | Cerebral aneurysm (HP:0004944) | 2.48851883 |
| 58 | Biconcave vertebral bodies (HP:0004586) | 2.47253866 |
| 59 | Plantar hyperkeratosis (HP:0007556) | 2.46884884 |
| 60 | Ketoacidosis (HP:0001993) | 2.45165223 |
| 61 | Blue sclerae (HP:0000592) | 2.45039824 |
| 62 | Fragile skin (HP:0001030) | 2.44277666 |
| 63 | Abnormality of proline metabolism (HP:0010907) | 2.42938034 |
| 64 | Hydroxyprolinuria (HP:0003080) | 2.42938034 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.39411956 |
| 66 | Flat acetabular roof (HP:0003180) | 2.33723897 |
| 67 | Stridor (HP:0010307) | 2.32955764 |
| 68 | Shallow orbits (HP:0000586) | 2.32607299 |
| 69 | Abnormal cartilage morphology (HP:0002763) | 2.31616839 |
| 70 | Milia (HP:0001056) | 2.31279396 |
| 71 | Distal upper limb amyotrophy (HP:0007149) | 2.31171492 |
| 72 | Upper limb amyotrophy (HP:0009129) | 2.31171492 |
| 73 | Mesangial abnormality (HP:0001966) | 2.30030124 |
| 74 | Hyperacusis (HP:0010780) | 2.28759456 |
| 75 | Skin nodule (HP:0200036) | 2.28685723 |
| 76 | Type 1 muscle fiber predominance (HP:0003803) | 2.27427022 |
| 77 | Testicular atrophy (HP:0000029) | 2.27266173 |
| 78 | Broad metatarsal (HP:0001783) | 2.27124922 |
| 79 | Ankle contracture (HP:0006466) | 2.27084498 |
| 80 | Abnormality of nucleobase metabolism (HP:0010932) | 2.26549584 |
| 81 | Onycholysis (HP:0001806) | 2.24794532 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.23062504 |
| 83 | Glomerulonephritis (HP:0000099) | 2.22974197 |
| 84 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.22837062 |
| 85 | Bladder diverticulum (HP:0000015) | 2.22662652 |
| 86 | Lymphangioma (HP:0100764) | 2.21440439 |
| 87 | Joint hemorrhage (HP:0005261) | 2.19865084 |
| 88 | Distal lower limb amyotrophy (HP:0008944) | 2.19312815 |
| 89 | Gout (HP:0001997) | 2.18077615 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17525170 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 2.17525170 |
| 92 | Steatorrhea (HP:0002570) | 2.17385653 |
| 93 | Elbow flexion contracture (HP:0002987) | 2.15363754 |
| 94 | Esophageal varix (HP:0002040) | 2.15170819 |
| 95 | Conjunctival hamartoma (HP:0100780) | 2.14624562 |
| 96 | Increased variability in muscle fiber diameter (HP:0003557) | 2.12962617 |
| 97 | Acanthosis nigricans (HP:0000956) | 2.12430750 |
| 98 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.11132718 |
| 99 | Palmoplantar hyperkeratosis (HP:0000972) | 2.10798019 |
| 100 | Asymmetric septal hypertrophy (HP:0001670) | 2.08184356 |
| 101 | Vascular calcification (HP:0004934) | 2.07918701 |
| 102 | Ulnar bowing (HP:0003031) | 2.07849507 |
| 103 | Generalized amyotrophy (HP:0003700) | 2.07122917 |
| 104 | Woolly hair (HP:0002224) | 2.06798849 |
| 105 | Vascular tortuosity (HP:0004948) | 2.05691768 |
| 106 | Wormian bones (HP:0002645) | 2.05254180 |
| 107 | Nephritis (HP:0000123) | 2.05099409 |
| 108 | Abnormality of methionine metabolism (HP:0010901) | 2.04373986 |
| 109 | Late onset (HP:0003584) | 2.03061637 |
| 110 | Broad face (HP:0000283) | 2.02926418 |
| 111 | Abnormality of the Achilles tendon (HP:0005109) | 2.01859180 |
| 112 | Abnormality of nail color (HP:0100643) | 2.00934340 |
| 113 | Coxa vara (HP:0002812) | 1.98805751 |
| 114 | Fragile nails (HP:0001808) | 1.98772554 |
| 115 | Axonal loss (HP:0003447) | 1.96764628 |
| 116 | Obstructive sleep apnea (HP:0002870) | 1.96183121 |
| 117 | Bulbar palsy (HP:0001283) | 1.96077386 |
| 118 | Neonatal onset (HP:0003623) | 1.94705383 |
| 119 | Metabolic acidosis (HP:0001942) | 1.94496669 |
| 120 | Aneurysm (HP:0002617) | 1.94122896 |
| 121 | Hyperbilirubinemia (HP:0002904) | 1.93757391 |
| 122 | Hemorrhage of the eye (HP:0011885) | 1.93430118 |
| 123 | Abdominal distention (HP:0003270) | 1.92933697 |
| 124 | Hepatocellular carcinoma (HP:0001402) | 1.92848663 |
| 125 | Pancreatitis (HP:0001733) | 1.91337611 |
| 126 | Hypertriglyceridemia (HP:0002155) | 1.90765927 |
| 127 | Follicular hyperkeratosis (HP:0007502) | 1.90357493 |
| 128 | Aortic regurgitation (HP:0001659) | 1.89831013 |
| 129 | Palmar hyperkeratosis (HP:0010765) | 1.87528733 |
| 130 | Hyperglycemia (HP:0003074) | 1.87162313 |
| 131 | Osteolytic defects of the hand bones (HP:0009699) | 1.86303759 |
| 132 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86303759 |
| 133 | Abnormality of dentin (HP:0010299) | 1.85776852 |
| 134 | Flat capital femoral epiphysis (HP:0003370) | 1.85361005 |
| 135 | Aortic aneurysm (HP:0004942) | 1.84925066 |
| 136 | Abnormal delivery (HP:0001787) | 1.84364172 |
| 137 | Nonimmune hydrops fetalis (HP:0001790) | 1.83000698 |
| 138 | Abnormality of carpal bone ossification (HP:0006257) | 1.82850821 |
| 139 | Mitral stenosis (HP:0001718) | 1.82586318 |
| 140 | Aortic dissection (HP:0002647) | 1.81680923 |
| 141 | Long toe (HP:0010511) | 1.80105747 |
| 142 | Arterial tortuosity (HP:0005116) | 1.79076560 |
| 143 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.79013583 |
| 144 | Cerebral palsy (HP:0100021) | 1.78906225 |
| 145 | Generalized aminoaciduria (HP:0002909) | 1.78667222 |
| 146 | Infantile muscular hypotonia (HP:0008947) | 1.78219383 |
| 147 | Ectopia lentis (HP:0001083) | 1.77466000 |
| 148 | Flattened epiphyses (HP:0003071) | 1.77155261 |
| 149 | Back pain (HP:0003418) | 1.76969253 |
| 150 | Soft skin (HP:0000977) | 1.76695140 |
| 151 | Cholelithiasis (HP:0001081) | 1.76320198 |
| 152 | Mitral regurgitation (HP:0001653) | 1.76270814 |
| 153 | Lethargy (HP:0001254) | 1.75808068 |
| 154 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.75438617 |
| 155 | Abnormal gallbladder morphology (HP:0012437) | 1.75173619 |
| 156 | Nuclear cataract (HP:0100018) | 1.75142781 |
| 157 | Hyperuricemia (HP:0002149) | 1.73327377 |
| 158 | Increased purine levels (HP:0004368) | 1.73327377 |
| 159 | Abnormality of the acetabulum (HP:0003170) | 1.72058393 |
| 160 | Acanthocytosis (HP:0001927) | 1.71624901 |
| 161 | Spinal rigidity (HP:0003306) | 1.71556982 |
| 162 | Abnormal gallbladder physiology (HP:0012438) | 1.70448454 |
| 163 | Osteoarthritis (HP:0002758) | 1.69555514 |
| 164 | Growth hormone excess (HP:0000845) | 1.69238654 |
| 165 | Exercise-induced myalgia (HP:0003738) | 1.69067447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 5.15353711 |
| 2 | ERN1 | 4.30720754 |
| 3 | TRIB3 | 3.50969661 |
| 4 | BCKDK | 3.37271252 |
| 5 | FRK | 2.92457083 |
| 6 | SIK1 | 2.71298879 |
| 7 | MET | 2.47697595 |
| 8 | EPHA2 | 2.34290318 |
| 9 | PKN2 | 2.34150939 |
| 10 | FGFR4 | 2.21763298 |
| 11 | PIK3CA | 2.15722362 |
| 12 | LATS1 | 2.01675792 |
| 13 | TTN | 2.01212889 |
| 14 | MAP3K3 | 2.01078220 |
| 15 | ICK | 2.00904396 |
| 16 | DDR2 | 1.89707715 |
| 17 | PDGFRA | 1.87534879 |
| 18 | MAP2K2 | 1.87389399 |
| 19 | IRAK3 | 1.87079121 |
| 20 | PTK6 | 1.86682682 |
| 21 | PIK3CG | 1.72152694 |
| 22 | SMG1 | 1.68329023 |
| 23 | RIPK1 | 1.63200831 |
| 24 | FER | 1.59350323 |
| 25 | MAP3K2 | 1.57142009 |
| 26 | MAPKAPK3 | 1.55193042 |
| 27 | PRKD2 | 1.54926522 |
| 28 | LIMK1 | 1.50767470 |
| 29 | TESK2 | 1.50114686 |
| 30 | ARAF | 1.49927931 |
| 31 | EPHB2 | 1.48279959 |
| 32 | MAP3K6 | 1.48099059 |
| 33 | MAP2K1 | 1.46155363 |
| 34 | LMTK2 | 1.44992537 |
| 35 | PRPF4B | 1.42029663 |
| 36 | PTK2 | 1.34267612 |
| 37 | MUSK | 1.32524999 |
| 38 | MAP2K3 | 1.23262188 |
| 39 | TAOK3 | 1.21335102 |
| 40 | FLT3 | 1.18529855 |
| 41 | TAOK1 | 1.17800317 |
| 42 | LRRK2 | 1.17688687 |
| 43 | EEF2K | 1.17528353 |
| 44 | MAP3K11 | 1.17427336 |
| 45 | EPHA3 | 1.17037202 |
| 46 | CDC42BPA | 1.16835443 |
| 47 | BMX | 1.14951907 |
| 48 | NTRK1 | 1.08811863 |
| 49 | RPS6KA2 | 1.06237069 |
| 50 | EPHB1 | 1.05992536 |
| 51 | ERBB4 | 1.03107122 |
| 52 | PRKD3 | 1.00417027 |
| 53 | KSR2 | 0.96413365 |
| 54 | MYLK | 0.91123367 |
| 55 | TESK1 | 0.90354703 |
| 56 | PRKG2 | 0.87418973 |
| 57 | LATS2 | 0.86564033 |
| 58 | TGFBR2 | 0.86204595 |
| 59 | MAPK11 | 0.85597569 |
| 60 | NEK9 | 0.84692465 |
| 61 | RPS6KB2 | 0.83795446 |
| 62 | VRK2 | 0.82859185 |
| 63 | MAP2K6 | 0.81659115 |
| 64 | NME1 | 0.81029632 |
| 65 | FGFR2 | 0.79577792 |
| 66 | MAP3K1 | 0.78868194 |
| 67 | MAP3K10 | 0.78581841 |
| 68 | SCYL2 | 0.75557541 |
| 69 | MARK2 | 0.75547402 |
| 70 | PAK2 | 0.71897964 |
| 71 | CAMK1D | 0.71731698 |
| 72 | TRPM7 | 0.70612048 |
| 73 | PDPK1 | 0.70513813 |
| 74 | TNK2 | 0.69950032 |
| 75 | INSRR | 0.68185769 |
| 76 | RPS6KA4 | 0.67245772 |
| 77 | STK38L | 0.67138858 |
| 78 | RPS6KC1 | 0.64737654 |
| 79 | RPS6KL1 | 0.64737654 |
| 80 | KDR | 0.63425431 |
| 81 | MST4 | 0.63103222 |
| 82 | STK38 | 0.62432420 |
| 83 | MAP3K7 | 0.61650580 |
| 84 | MAP3K8 | 0.60374506 |
| 85 | ABL2 | 0.60124315 |
| 86 | PHKG1 | 0.58863204 |
| 87 | PHKG2 | 0.58863204 |
| 88 | TYK2 | 0.58710260 |
| 89 | CDK6 | 0.58556010 |
| 90 | KIT | 0.58272450 |
| 91 | ERBB2 | 0.56698917 |
| 92 | TGFBR1 | 0.56666103 |
| 93 | RPS6KA6 | 0.56381451 |
| 94 | TAOK2 | 0.56245352 |
| 95 | PAK4 | 0.55815036 |
| 96 | MTOR | 0.55256143 |
| 97 | NUAK1 | 0.55003794 |
| 98 | DYRK1B | 0.53975747 |
| 99 | PAK3 | 0.53240152 |
| 100 | PRKAA2 | 0.52339990 |
| 101 | MAPK15 | 0.51661863 |
| 102 | PIM2 | 0.51578565 |
| 103 | ZAP70 | 0.50599939 |
| 104 | FGFR1 | 0.49080232 |
| 105 | TBK1 | 0.48189016 |
| 106 | IRAK2 | 0.47670713 |
| 107 | PDGFRB | 0.46970585 |
| 108 | JAK2 | 0.45765679 |
| 109 | STK10 | 0.45470866 |
| 110 | JAK1 | 0.45103948 |
| 111 | HIPK2 | 0.44142455 |
| 112 | RET | 0.43915377 |
| 113 | ILK | 0.43655264 |
| 114 | GSK3A | 0.42600937 |
| 115 | PDK3 | 0.41378815 |
| 116 | PDK4 | 0.41378815 |
| 117 | PDK2 | 0.40988588 |
| 118 | PRKCI | 0.40203269 |
| 119 | ROCK1 | 0.38788280 |
| 120 | CAMK2G | 0.38283526 |
| 121 | CDK8 | 0.37398980 |
| 122 | MAPK12 | 0.36407285 |
| 123 | FGFR3 | 0.35597170 |
| 124 | CAMK2D | 0.35447112 |
| 125 | DAPK3 | 0.34063950 |
| 126 | DMPK | 0.33832179 |
| 127 | MOS | 0.32893240 |
| 128 | CAMK2B | 0.32830837 |
| 129 | CAMK1G | 0.32703733 |
| 130 | MAPK4 | 0.30787713 |
| 131 | MAPKAPK2 | 0.28821019 |
| 132 | CHUK | 0.28570477 |
| 133 | NME2 | 0.28062937 |
| 134 | STK3 | 0.28061250 |
| 135 | GRK6 | 0.26584894 |
| 136 | PRKD1 | 0.26175782 |
| 137 | TIE1 | 0.25994591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.36187538 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12391513 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.67290800 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55505092 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53202530 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50717949 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41002146 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.33045376 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.31938484 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27810891 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.27630918 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.22571611 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.20342919 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.17745469 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14681694 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13514932 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04778801 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.98852472 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95073173 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.92953227 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90867625 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90815706 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.90046707 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88691414 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83885266 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.73875829 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73593349 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.73094411 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.71271407 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.57912625 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51033185 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49218299 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.46788991 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.46422872 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43498108 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42417235 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42416643 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40052788 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36330177 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34671928 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33375292 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29119253 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22614800 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21950267 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21304632 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.21122253 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17828978 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.10403820 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09349696 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09043069 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.07398996 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06983118 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05959798 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05331152 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04326206 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03868481 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03094247 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03046429 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01276724 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.00618600 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90451576 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.84088322 |
| 63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83675958 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83118807 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81884211 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.81842297 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79595231 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78918715 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76729614 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.73421569 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.72818885 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72793767 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71093120 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70682176 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68548122 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66094487 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66047965 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65231116 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62646153 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60478244 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.60014363 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59655408 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57935832 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55741064 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54879927 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53583026 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50281293 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49338827 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45668177 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.43448223 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41834257 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.41582287 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40833318 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40228106 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36483550 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35252720 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.34885106 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33839733 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30931779 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29934510 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27253327 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24627213 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.23689728 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.22225530 |
| 105 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.20163052 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20090804 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.18767249 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.18142591 |
| 109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17961063 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17485550 |
| 111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.17226555 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15012192 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.14832665 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.12604454 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.11135644 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10518978 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09571667 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08359316 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.08163308 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.05324984 |

